Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.22B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Danaher
DHR
|
+$293M |
| 4 |
Linde
LIN
|
+$281M |
| 5 |
Carlyle Group
CG
|
+$268M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$926M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$770M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$649M |
| 4 |
Meta Platforms (Facebook)
META
|
+$641M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$462M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.07% |
| 2 | Financials | 9% |
| 3 | Technology | 7.77% |
| 4 | Healthcare | 6.87% |
| 5 | Industrials | 5.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
3526
PUT
Carlyle Group
CG
$17.5B
| $2.34M | ﹤0.01% |
+53,700
| New | +$2.66M |
|
3527
KULR Technology Group
KULR
$119M
| $2.34M | ﹤0.01% |
221,658
+190,504
| +611% | +$2.98M |
|
3528
Coherus Oncology
CHRS
$218M
| $2.34M | ﹤0.01% |
2,899,952
+1,850,349
| +176% | +$2.13M |
|
3529
Haemonetics
HAE
$4.73B
| $2.34M | ﹤0.01% |
36,806
-125,501
| -77% | -$8.54M |
|
3530
Thor Industries
THO
$4.01B
| $2.33M | ﹤0.01% |
30,762
-180,307
| -85% | -$17M |
|
3531
iShares TIPS Bond ETF
TIP
$15B
| $2.33M | ﹤0.01% |
20,956
+3,100
| +17% | +$337K |
|
3532
MGE Energy Inc
MGEE
$2.95B
| $2.32M | ﹤0.01% |
24,997
-81,614
| -77% | -$7.43M |
|
3533
CALL
Wheaton Precious Metals
WPM
$69.6B
| $2.32M | ﹤0.01% |
29,900
+25,500
| +580% | +$1.7M |
|
3534
PUT
Regions Financial
RF
$25.8B
| $2.32M | ﹤0.01% |
106,800
+95,200
| +821% | +$2.22M |
|
|
GLDD
3535
DELISTED
Great Lakes Dredge & Dock
GLDD
| $2.32M | ﹤0.01% |
266,559
-431,512
| -62% | -$4.3M |
|
3536
PUT
GE HealthCare
GEHC
$32.4B
| $2.32M | ﹤0.01% |
28,700
-14,200
| -33% | -$1.22M |
|
3537
Nutrien
NTR
$35.1B
| $2.32M | ﹤0.01% |
46,618
-3,924,377
| -99% | -$201M |
|
|
PLYM
3538
DELISTED
Plymouth Industrial REIT
PLYM
| $2.31M | ﹤0.01% |
141,978
+129,491
| +1,037% | +$2.18M |
|
3539
Akebia Therapeutics
AKBA
$243M
| $2.31M | ﹤0.01% |
1,203,852
+1,034,205
| +610% | +$2.11M |
|
|
HYAC.U
3540
DELISTED
Haymaker Acquisition Corp 4 Units
HYAC.U
| $2.31M | ﹤0.01% |
210,000
| – | – |
|
3541
PUT
Zimmer Biomet
ZBH
$19.2B
| $2.31M | ﹤0.01% |
20,400
-10,400
| -34% | -$1.11M |
|
3542
Kimbell Royalty Partners
KRP
$1.5B
| $2.31M | ﹤0.01% |
164,840
+91,889
| +126% | +$1.39M |
|
3543
Globalstar
GSAT
$10.6B
| $2.3M | ﹤0.01% |
110,291
-30,089
| -21% | -$728K |
|
3544
Qualys
QLYS
$6.47B
| $2.3M | ﹤0.01% |
18,231
-18,032
| -50% | -$2.44M |
|
3545
PUT
Alnylam Pharmaceuticals
ALNY
$31.7B
| $2.3M | ﹤0.01% |
8,500
-4,800
| -36% | -$1.23M |
|
3546
CALL
Martin Marietta Materials
MLM
$37.7B
| $2.3M | ﹤0.01% |
4,800
+2,600
| +118% | +$1.32M |
|
3547
Visteon
VC
$2.72B
| $2.29M | ﹤0.01% |
29,496
-189,936
| -87% | -$16M |
|
|
KALV
3548
DELISTED
KalVista Pharmaceuticals
KALV
| $2.29M | ﹤0.01% |
+198,205
| New | +$2.02M |
|
3549
CorMedix
CRMD
$647M
| $2.29M | ﹤0.01% |
371,126
+192,992
| +108% | +$2M |
|
3550
Humacyte
HUMA
$181M
| $2.28M | ﹤0.01% |
1,340,083
+421,229
| +46% | +$1.58M |
|
Similar funds
Israel Englander's Q1 2025 Portfolio in Review
As of Q1 2025, Israel Englander held 6,639 positions worth $188B, down 8.2% from $205B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Israel Englander withdrew a net $10.2B in Q1 2025, closing 852 positions and reducing 2,261 holdings. Its most notable exit was Verizon, an estimated $263M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 50% a quarter earlier, followed by Financials and Technology.
Against the trend, Israel Englander opened a new position in Blackrock worth $215M.
- Israel Englander's largest Q1 2025 buy was Blackrock: 227,394 shares worth $215M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $2.22B increase.
- Israel Englander's biggest Q1 2025 reduction was Broadcom, cutting an estimated $926M.
- Israel Englander fully exited Verizon in Q1 2025, selling an estimated $263M.
- Israel Englander's ten largest holdings make up 16% of its $188B portfolio in Q1 2025.
- Israel Englander opened 739 new positions and closed 852 in Q1 2025.
- Israel Englander's portfolio value fell 8.2% quarter-over-quarter to $188B.
Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.